4//SEC Filing
Koneru Mythili 4
Accession 0001209191-22-011779
CIK 0001094038other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:07 PM ET
Size
5.7 KB
Accession
0001209191-22-011779
Insider Transaction Report
Form 4
Koneru Mythili
Snr VP, Clinical Development
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-17+160,000→ 160,000 totalExercise: $0.46Exp: 2032-02-17→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001776659
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:07 PM ET
- Size
- 5.7 KB